Early Detection of Chronic Kidney Disease in Dogs and Cats: The Role of SDMA

Chronic kidney disease (CKD) is one of the most common diseases of ageing dogs and cats, yet it is frequently diagnosed late — after substantial and irreversible nephron loss has already occurred. The introduction of symmetric dimethylarginine (SDMA) as a routine biomarker has fundamentally changed how early we can detect this disease.

The Problem with Creatinine

Creatinine has long been the standard screening marker for renal function, but it has a critical limitation: it does not rise above the reference interval until roughly 60–70% of kidney function is lost. By the time creatinine is elevated, the disease is often well advanced.

Creatinine is also influenced by muscle mass, meaning results can be misleading in:

Cachectic or geriatric patients (falsely low)
Young, muscular animals (falsely high)
Animals that have recently lost body condition

Why SDMA Is Different

SDMA is produced at a constant rate by all nucleated cells and is eliminated almost entirely by renal filtration. Crucially, SDMA:

Rises earlier — with as little as 25–40% loss of kidney function
Is muscle-mass independent — reliable across body types and life stages
Correlates with glomerular filtration rate (GFR) — the gold standard of renal function

What This Means in Practice

Because SDMA detects declining function earlier, clinicians can:

Diagnose CKD sooner — often months before creatinine becomes abnormal
Stage the disease more accurately — enabling earlier IRIS staging
Intervene earlier — with renal diets, blood pressure control, and targeted therapy
Monitor progression — with serial quantitative measurements

Integrating SDMA into Your Diagnostic Workflow

Quantitative SDMA testing on an immunofluorescence analyzer delivers results in minutes, making it practical for routine screening during annual wellness visits, pre-anaesthetic workups, and monitoring of at-risk breeds. Used alongside creatinine and urinalysis, SDMA provides a more complete picture of renal health.

Summary

Early detection changes outcomes. By adopting SDMA as a first-line renal biomarker, veterinary teams can identify chronic kidney disease before irreversible damage accumulates — giving patients more years of healthy life and owners more informed care decisions.